維生素 D 治療市場：依給藥途徑、購買模式、年齡層、適應症分類 - 2023-2030 年全球預測

全球維生素D治療市場預計到2023年將大幅成長，達到32.0525億美元，複合年成長率為12.73%，到2030年將達到74.266億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球維生素D治療市場至關重要。透過檢視業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使用戶能夠根據自己的具體需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解自家公司在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.維生素D療法的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球維生素 D 治療市場的阻礙因素和影響為何？

3. 在預測期內，全球維生素 D 治療市場需要投資哪些產品/細分市場/用途/領域？

4. 全球維生素D治療市場的競爭策略是什麼？

5. 全球維生素D治療市場的技術趨勢和法律規範是什麼？

6.全球維生素D治療市場主要供應商的市佔率是多少？

7. 哪些型態和策略性舉措被認為適合進入全球維生素D治療市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 美國維生素 D 缺乏症病例呈上升趨勢
    • 目標患者群大
    • 人們對維生素 D 療法的認知不斷提高
  • 抑制因素
    • 有限的臨床試驗
  • 機會
    • 營養不良普遍存在的國家的成長機會增加
    • 增加研發活動以開發有效的維生素 D 療法
  • 任務
    • 強化食品的供應
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化
  • 消費趨勢
  • 各地區維生素D缺乏症流行病學資料

第6章 維生素 D 治療市場：依給藥途徑

• 介紹
• 口服給藥
• 腸外給藥

第7章 維生素D治療市場：依購買模式分類

• 介紹
• 非處方藥物
• 處方藥

第8章 維生素 D 治療市場：依年齡層

• 介紹
• 成人
• 嬰兒

第9章 維生素 D 治療市場：依適應症分類

• 介紹
• 自體免疫疾病
• 肌肉無力
• 骨質疏鬆症
• 疳
• 皮膚病

第10章 美洲維生素D治療市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太維生素D治療市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲維生素D治療市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和定價

The Global Vitamin D Therapy Market is forecasted to grow significantly, with a projected USD 3,205.25 million in 2023 at a CAGR of 12.73% and expected to reach a staggering USD 7,426.60 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vitamin D Therapy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vitamin D Therapy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Route of Administration, market is studied across Oral Route of Administration and Parenteral Route of Administration. The Parenteral Route of Administration is projected to witness significant market share during forecast period.

Based on Purchasing Pattern, market is studied across Over-The-Counter Drugs and Prescription Drugs. The Over-The-Counter Drugs is projected to witness significant market share during forecast period.

Based on Age Group, market is studied across Adults and Children. The Adults is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Autoimmune Disorders, Muscle Weakness, Osteoporosis, Rickets, and Skin Diseases. The Muscle Weakness is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vitamin D Therapy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vitamin D Therapy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vitamin D Therapy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vitamin D Therapy Market?

4. What is the competitive strategic window for opportunities in the Global Vitamin D Therapy Market?

5. What are the technology trends and regulatory frameworks in the Global Vitamin D Therapy Market?

6. What is the market share of the leading vendors in the Global Vitamin D Therapy Market?

7. What modes and strategic moves are considered suitable for entering the Global Vitamin D Therapy Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Vitamin D Therapy Market, by Route of Administration, 2022 vs 2030
• 4.3. Vitamin D Therapy Market, by Purchasing Pattern, 2022 vs 2030
• 4.4. Vitamin D Therapy Market, by Age Group, 2022 vs 2030
• 4.5. Vitamin D Therapy Market, by Indication, 2022 vs 2030
• 4.6. Vitamin D Therapy Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of vitamin D deficiency in the U.S.
    • 5.1.1.2. Presence of a large target patient population
    • 5.1.1.3. Growing awareness regarding vitamin D therapy
  • 5.1.2. Restraints
    • 5.1.2.1. Limited clinical Trials
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing growth opportunities in countries with a high prevalence of undernutrition
    • 5.1.3.2. Rise in R&D activities for development of efficient vitamin D therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of fortified foods
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Consumption Trend
  • 5.9.2. Epidemiological Data about Vitamin-D Deficiency across Geographies

6. Vitamin D Therapy Market, by Route of Administration

• 6.1. Introduction
• 6.2. Oral Route of Administration
• 6.3. Parenteral Route of Administration

7. Vitamin D Therapy Market, by Purchasing Pattern

• 7.1. Introduction
• 7.2. Over-The-Counter Drugs
• 7.3. Prescription Drugs

8. Vitamin D Therapy Market, by Age Group

• 8.1. Introduction
• 8.2. Adults
• 8.3. Children

9. Vitamin D Therapy Market, by Indication

• 9.1. Introduction
• 9.2. Autoimmune Disorders
• 9.3. Muscle Weakness
• 9.4. Osteoporosis
• 9.5. Rickets
• 9.6. Skin Diseases

10. Americas Vitamin D Therapy Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Vitamin D Therapy Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Vitamin D Therapy Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. VITAMIN D THERAPY MARKET RESEARCH PROCESS
• FIGURE 2. VITAMIN D THERAPY MARKET SIZE, 2022 VS 2030
• FIGURE 3. VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
• FIGURE 5. VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2022 VS 2030 (%)
• FIGURE 6. VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
• FIGURE 7. VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 8. VITAMIN D THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. VITAMIN D THERAPY MARKET DYNAMICS
• FIGURE 10. VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. VITAMIN D THERAPY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 5. VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 8. VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 11. VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 14. VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. CHINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 56. CHINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 57. CHINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. INDIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 60. INDIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 61. INDIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. ITALY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. ITALY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 129. ITALY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 130. ITALY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. POLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 144. POLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 145. POLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 146. POLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. QATAR VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 148. QATAR VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 149. QATAR VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 150. QATAR VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 188. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 189. VITAMIN D THERAPY MARKET LICENSE & PRICING